Country: United States
Language: English
Source: NLM (National Library of Medicine)
MELOXICAM (UNII: VG2QF83CGL) (MELOXICAM - UNII:VG2QF83CGL)
BUTLER ANIMAL HEALTH SUPPLY, LLC DBA COVETRUS NORTH AMERICA
SUBCUTANEOUS
PRESCRIPTION
Dogs: Meloxicam Injection is indicated in dogs for the control of pain and inflammation associated with osteoarthritis. Dogs with known hypersensitivity to meloxicam should not receive Meloxicam Injection. Cats: For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery. Cats with known hypersensitivity to meloxicam should not receive Meloxicam Injection. Additional doses of meloxicam or other NSAIDs in cats are contraindicated, as no safe dosage for repeated NSAID administration has been established (See Animal Safety). Do not use meloxicam in cats with pre-existing renal dysfunction.
Meloxicam 5 mg/mL Solution for Injection: 10 mL vial and 20 mL vial NDC no. 11695-7008-1 10 mL / NDC no. 11695-7008-2 20 mL Meloxicam 5 mg/mL Solution for Injection: 10 mL vial and 20 mL vial NDC no. 11695-7008-1 10 mL / NDC no. 11695-7008-2 20 mL
Abbreviated New Animal Drug Application
MELOXICAM- MELOXICAM INJECTION, SOLUTION BUTLER ANIMAL HEALTH SUPPLY, LLC DBA COVETRUS NORTH AMERICA ---------- MELOXICAM INJECTION 5 MG/ML SOLUTION FOR INJECTION PACKAGE INSERT FOR DOGS Non-steroidal anti-inflammatory drug for use in dogs and cats only CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. WARNING: REPEATED USE OF MELOXICAM IN CATS HAS BEEN ASSOCIATED WITH ACUTE RENAL FAILURE AND DEATH. DO NOT ADMINISTER ADDITIONAL INJECTABLE OR ORAL MELOXICAM TO CATS. SEE CONTRAINDICATIONS, WARNINGS, AND PRECAUTIONS FOR DETAILED INFORMATION. DESCRIPTION: Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class. Each mL of this sterile product for injection contains meloxicam 5.0 mg, alcohol 15%, glycofurol 10%, poloxamer 188 5%, sodium chloride 0.6%, glycine 0.5% and meglumine 0.3%, in water for injection, pH adjusted with sodium hydroxide and hydrochloric acid. INDICATIONS: DOGS: Meloxicam Injection is indicated in dogs for the control of pain and inflammation associated with osteoarthritis. DOSAGE AND ADMINISTRATION: Carefully consider the potential benefits and risk of Meloxicam and other treatment options before deciding to use Meloxicam. Use the lowest effective dose for the shortest duration consistent with individual response. DOGS: Meloxicam Injection should be administered initially as a single dose at 0.09 mg/lb (0.2 mg/kg) body weight intravenously (IV) or subcutaneously (SQ), followed, after 24 hours, by meloxicam oral suspension at the daily dose of 0.045 mg/lb (0.1 mg/kg) body weight, either mixed with food or placed directly in the mouth. CONTRAINDICATIONS: Dogs with known hypersensitivity to meloxicam should not receive Meloxicam Injection. WARNINGS: Not for use in humans. Keep this and all medications out of reach of children. Consult a physician in case of accidental ingestion by humans. For IV or SQ injectable use in dogs. All dogs should undergo a thorough history and physical examination before administering any NSAID. Approp Read the complete document